Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
3,685
3,685 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- SRP-1001ARO-DUX4Phase 21 trial
Sarepta Therapeutics, Inc. · Muscular Dystrophy, Facioscapulohumeral
- SRP-1003ARO-DM1Phase 21 trial
Sarepta Therapeutics, Inc. · Myotonic Dystrophy 1
- SRP1020Phase 21 trial
Shanghai SciBrunch Therapeutics Co., Ltd. · Advanced Solid Tumors, PARP Inhibitor
- SRSD216Phase 21 trial
Sirius Therapeutics Co., Ltd. · Hyperlipoproteinemia (a)
- SRSD384Phase 21 trial
Sirius Therapeutics Co., Ltd. · Overweight , Obesity
- SRX246Phase 21 trial
Azevan Pharmaceuticals · Aggressive Behavior in Fragile X Syndome
- SSGJ-613Phase 21 trial
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. · Gout Arthritis
- SSS06Phase 21 trial
Shenyang Sunshine Pharmaceutical Co., LTD. · Chemotherapy-induced Anemia, Non-myeloid Malignancies
- ST-01Phase 21 trial
Sustained Therapeutics Inc. · Chronic Pain
- ST-067Phase 21 trial
Simcha IL-18, Inc. · Cancer, Solid Tumor, Melanoma
- ST-920Phase 21 trial
Sangamo Therapeutics · Fabry Disease
- ST101Phase 21 trial
Sapience Therapeutics · Glioblastoma, Melanoma Stage IV, Breast Cancer
- ST266Phase 21 trial
Noveome Biotherapeutics, formerly Stemnion · Necrotizing Enterocolitis
- STC-1010Phase 21 trial
Brenus Pharma · Unresectable Metastatic Colorectal Cancer, Unresectable Locally Advanced Colorectal Cancer
- STC-15Phase 21 trial
STORM Therapeutics LTD · Solid Tumor, Sarcoma, Leiomyosarcoma
- STI-6129Phase 21 trial
Zhejiang ACEA Pharmaceutical Co. Ltd. · Relapsed or Refractory Multiple Myeloma
- STK-012Phase 21 trial
Synthekine · Advanced Solid Tumor, Non Small Cell Lung Cancer, Untreated Advanced NSCLC
- STM-416Phase 21 trial
SURGE Therapeutics · Non-muscle-invasive Bladder Cancer
- STMC-103HPhase 21 trial
Siolta Therapeutics, Inc. · Atopic Dermatitis, Type 1 Hypersensitivity
- STP705Phase 21 trial
Sirnaomics · Submental Fullness
- STRO-002Phase 21 trial
Tasly Pharmaceutical Group Co., Ltd · Neoplasm Malignant
- STSA-1301Phase 21 trial
Jiangsu BioJeTay Biotechnology Co., Ltd. · Primary Immune Thrombocytopenia (ITP)
- STX-001Phase 21 trial
Strand Therapeutics Inc. · Advanced Solid Tumor
- STX-003Phase 21 trial
Strand Therapeutics Inc. · Advanced Solid Tumor
- STX-241PFL-241Phase 21 trial
Pierre Fabre Medicament · Non-small Cell Lung Cancer (NSCLC)
- STX-721PFL-721, EscalatedPhase 21 trial
Pierre Fabre Medicament · Non-Small Cell Lung Cancer, NSCLC, EGFR/HER2 Exon 20 Insertion Mutation
- SUL-238t.i.d.Phase 21 trial
GEN İlaç ve Sağlık Ürünleri A.Ş. · Parkinson's Disease (PD)
- SUM-191Phase 21 trial
Senju USA, Inc. · Bacterial Conjunctivitis
- SUN-627NEU-627, N-004850Phase 21 trial
Sundance Biosciences, Inc. · Primary Progressive Multiple Sclerosis, Primary Progressive MS, Primary Progressive Multiple Sclerosis (PPMS)
- SV-102Phase 21 trial
Syncromune, Inc. · Metastatic Castration-resistant Prostate Cancer
- SV001Phase 21 trial
Shanghai Synvida Biotechnology Co.,Ltd. · Idiopathic Pulmonary Fibrosis(IPF)
- SX-682Phase 21 trial
Syntrix Biosystems, Inc. · Metastatic Castration-resistant Prostate Cancer
- SXR1096Phase 21 trial
Sixera Pharma · Netherton Syndrome
- SYH2059Phase 21 trial
InnovStone Therapeutics Limited · Idiopathic Pulmonary Fibrosis
- SYH2062Phase 21 trial
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. · Mild to Moderate Primary Hypertension
- SYH2066Phase 21 trial
CSPC Ouyi Pharmaceutical Co., Ltd. · Respiratory Syncytial Virus Infections
- SYH2068Phase 21 trial
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. · Adult Participants With Elevated Lipoprotein(a)
- SYH2070Phase 21 trial
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. · Mixed Hyperlipidemia
- SYH2085Phase 21 trial
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · Influenza
- SYH9061Phase 21 trial
CSPC-NBP Pharmaceutical Co., Ltd. · Idiopathic Pulmonary Fibrosis
- SYHX2011Phase 21 trial
CSPC Ouyi Pharmaceutical Co., Ltd. · Advanced Breast Cancer
- SYL1801Phase 21 trial
Sylentis, S.A. · Wet Macular Degeneration, Neovascular Age-related Macular Degeneration, Macular Degeneration
- SYN-004Phase 21 trial
Theriva Biologics, Inc. · Acute Graft-Versus-Host Reaction Following Bone Marrow Transplant, Prevention of CDI in Adult Patients Being Treated With IV Beta-lactam Antibiotics
- SYN321Phase 21 trial
Synartro AB · Osteoarthritis of Knee
- SYS6006Phase 21 trial
CSPC Megalith Biopharmaceutical Co.,Ltd. · Advanced Solid Tumors
- SYS6023Phase 21 trial
CSPC Megalith Biopharmaceutical Co.,Ltd. · Advanced Breast Cancer
- SYS6026Phase 21 trial
CSPC Megalith Biopharmaceutical Co.,Ltd. · High-grade Cervical Intraepithelial Lesions
- SYS6045Phase 21 trial
CSPC Megalith Biopharmaceutical Co.,Ltd. · Advanced Solid Tumors
- SYS6062Phase 21 trial
CSPC Megalith Biopharmaceutical Co.,Ltd. · Advanced Solid Tumors, Gastric Cancer (GC), Colorectal Cancer (CRC)
- SYS6088Phase 21 trial
CSPC Megalith Biopharmaceutical Co.,Ltd. · Advanced/Metastatic Solid Tumors
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.